Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Tandem Diabetes Care (TNDM)

Tandem Diabetes Care completes $300 million convertible notes offering due 2032

Neutral Impact 3 of 5 financing Written later

Tandem Diabetes Care completed a private offering of $300.0 million of 0.00% convertible senior notes due March 15, 2032, including a $35.0 million option exercised in full by the initial purchasers. The notes carry no regular interest and are convertible into cash, shares, or a combination, at the company's election, at an initial conversion price of about $36.99 per share. The company adds this debt to its balance sheet, and dilution from conversion is partly offset by capped call transactions subject to a cap.

Key points

  • $300.0 million principal, including the $35.0 million option exercised in full; notes mature March 15, 2032
  • Initial conversion price of about $36.99 per share, a premium of about 37.5% to the February 24, 2026 last reported sale price
  • Net proceeds of about $290.7 million after discounts and offering expenses; $15.3 million used to pay the cost of the capped call transactions
  • The company may not redeem the notes before March 20, 2029

The filing

CompanyTandem Diabetes Care (TNDM)
Form8-K, current report
Filed with the SECFeb 27, 2026, 4:06 PM ET
Accession number0001140361-26-007142

Items reported: 1.01 Material Definitive Agreement2.03 New Direct Financial Obligation3.02 Unregistered Equity Sale8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:59 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 27, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.